Analysts Lift Targets, Insiders Sell, as HOOD Trades 30% Below Consensus
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Robinhood Markets enters Tuesday's Q3 print down 23% over the past month to $95.07, while the average analyst price target has climbed to $134.90, leaving a gap of roughly 42% between where the Street thinks the stock is worth and where it is actually trading.
The disconnect between analyst optimism and price performance is the defining feature of the setup. The past two weeks brought an unusual volume of upward revisions: Morgan Stanley raised its target to $160 from $150, Bank of America went to $156 from $140, Barclays lifted to $132 from $105, and Rosenblatt opened fresh coverage at Buy with a $135 target. JP Morgan, more cautiously positioned at Neutral, still raised its target to $115 from $103. The direction of travel is almost uniformly up. Against that, short interest has risen 15% over the past month to 5.3% of the free float at 41.3 million shares, though it has edged down fractionally in the past week. The borrow market remains relaxed: availability is at 1,317%, more than 13 shares available for every one already lent out, and cost to borrow is 0.49%. Bears are adding on a monthly basis, but they are doing so into a very deep lending pool at minimal cost.
Insider activity pulls in the opposite direction from analyst enthusiasm. CEO Vladimir Tenev sold approximately $42.6 million worth of shares on October 5, and co-founder Baiju Bhatt added a further $5.2 million in sales on October 21. Both sets of trades were made under pre-arranged 10b5-1 plans, which limits the signal, but the 90-day net insider position is a disposal of nearly 1 million shares worth roughly $119 million. That scale of planned selling into a falling stock is the kind of number a holder notices. Bhatt, despite the sales, retains approximately 6.1% of shares outstanding, and Tenev holds close to 6.0%, so both remain deeply invested in the outcome.
The bull case rests on platform breadth: 13 product lines generating over $100 million annually, 27 million active accounts, and $322 billion in customer assets, with crypto, prediction markets, and Robinhood Chain cited as incremental growth vectors. The bear case is simpler: growth is still driven by volatile retail trading activity and payment for order flow, and the newer product lines add execution and regulatory risk without eliminating dependence on market volumes. Options positioning leans modestly toward caution, with the put/call ratio at 0.70, about one standard deviation above its 20-day average, and near the top of its 52-week range. That is not a sharp defensive skew, but it is directionally consistent with a market that wants downside protection ahead of the release. The one prior earnings print in the history data saw the stock fall 6.6% on the day before recovering to near flat over the following five sessions.
The Q3 report on October 27 tests whether record engagement and expanding product revenue can justify a valuation that trades at 29.7x trailing earnings, with the PE multiple down nearly nine points over the past month, or whether the Street's target-raising cycle runs ahead of a fundamental story still tied closely to the mood of the retail trading market.
Stocks in this article
See the live data behind this article on ORTEX.
Open HOOD on ORTEX →How this article was generated
- Generated
- 24 Oct 2026, 04:31
- Data as of
- 24 Oct 2026, 04:02
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.